Filing Details
- Accession Number:
- 0001214659-21-009575
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-16 18:30:10
- Reporting Period:
- 2021-09-14
- Accepted Time:
- 2021-09-16 18:30:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1677077 | Alzamend Neuro Inc. | ALZN | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1212502 | Iii C Milton Ault | 3802 Spectrum Boulevard, Suite 112C Tampa FL 33612 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-14 | 5,000 | $2.70 | 6,720,388 | No | 4 | P | Indirect | By Digital Power Lending, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Digital Power Lending, LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Call Option (right to buy) | Acquisiton | 2021-09-16 | 180 | $93.39 | 18,000 | $2.50 |
| Common Stock | Call Option (right to buy) | Acquisiton | 2021-09-16 | 200 | $25.51 | 20,000 | $10.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 300 | 2022-02-18 | No | 4 | P | Indirect | |
| 400 | 2022-02-18 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 150,000 | Direct | |
| Common Stock | 15,000,000 | Indirect | By Ault Life Sciences, Inc. |
| Common Stock | 10,000,000 | Indirect | By Ault Life Sciences Fund, LLC |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Call Option (right to buy) | $5.00 | 2022-02-18 | 50,000 | 500 | Indirect | |
| Common Stock | Call Option (right to buy) | $7.50 | 2022-02-18 | 5,000 | 50 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-02-18 | 50,000 | 500 | Indirect |
| 2022-02-18 | 5,000 | 50 | Indirect |
Footnotes
- Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
- Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
- Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
- The security listed is an exchange-traded option contract. Exchange-traded options are immediately exercisable and remain exercisable until expiration.
- The options were purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $93.3891. The range of purchase prices on the transaction date was $91.511 to $96.511. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of options purchased at each price.
Billionaire Hedge Funds
